Recognized for excellence in writing, news, mental health, financial/investment and economics categories
LONDON, July 18, 2024 /PRNewswire/ -- BioWorld [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=1890695305&u=http%3A%2F%2Fwww.bioworld.com%2F&a=BioWorld](TM) published by Clarivate Plc [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2787808492&u=http%3A%2F%2Fwww.clarivate.com%2F&a=Clarivate+Plc] , a leading global provider of transformative intelligence, has been honored with nine 2024 APEX Awards for Publication Excellence. [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2987248934&u=https%3A%2F%2Fapexawards.com%2Fwinners-2024&a=2024+APEX+Awards+for+Publication+Excellence.] This achievement underscores the BioWorld mission to deliver superior journalistic excellence, data-driven analysis and cutting-edge digital publishing.
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg [https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg]
The APEX Awards, now in their 36th year, recognize outstanding work by professional communicators in areas such as graphic design, editorial content, and overall communications excellence. With over 1,100 entries this year, the competition was fierce, making these nine wins a testament to the continued leadership and innovation in the field by BioWorld.
Lynn Yoffee, Publisher, BioWorld, said: "This recognition from the APEX Awards is a testament to our team's unwavering dedication to journalistic excellence. In a fast-paced and ever-changing industry, BioWorld remains a leader through our insightful analysis and compelling storytelling, providing crucial insights into the development of therapeutics and devices, the companies driving these innovations, the business deals shaping the market, and the regulatory challenges that safeguard the process. We are proud to be at the forefront of delivering critical information that drives innovation and improves lives worldwide."
Henry Levy, President, Life Science and Healthcare, Clarivate, said: "The BioWorld suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. They also make all of our products across Cortellis and our RWD solutions stronger by aligning to the key occurrences in the market. The accolades received from the APEX Awards reflect the ongoing dedication of the BioWorld team to producing award-winning journalism that resonates with readers and the publishing industry alike."
APEX Grand Awards honor outstanding works in each main category and Awards of Excellence recognize exceptional entries in the sub-categories. BioWorld has been recognized in the following 2024 APEX Awards categories:
-- Grand Award - Writing Category: Annette Boyle, BioWorld MedTech Cytovale
gets FDA nod for 10-minute sepsis test
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2030260025&u=https%3A%2
F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%25
2Fwww.bioworld.com%252Farticles%252F693414-cytovale-gets-fda-nod-for-10-
minute-sepsis-test%26data%3D05%257C02%257CCatherine.Daniel%2540Clarivate
.com%257Cedc5fea15e914277fdcd08dca1c9b39b%257C127fa96e00b4429e95f972c282
8437a4%257C0%257C0%257C638563134905138152%257CUnknown%257CTWFpbGZsb3d8ey
JWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0
%257C%257C%257C%26sdata%3D2zFfLo8989b4dbh88AmTFhbgBEqBioY1SKfycfdr4nk%25
3D%26reserved%3D0&a=Cytovale+gets+FDA+nod+for+10-minute+sepsis+test]
Cytovale Inc. received U.S. FDA 510(k) clearance for its Intellisep
sepsis test, which can aid in the diagnosis of the often-fatal condition
within 10 minutes. Cytovale is one of several companies and
collaborations that aim to sharply reduce the time to diagnosis and the
mortality rate for sepsis by providing quicker, more informative test
results and standardizing protocols.
-- Grand Award - Writing Category: Nuala Moran, BioWorld MedTech, BioWorld,
and BioWorld Science Let there be walk: Onward Medical sees first use of
movement-restoring lead
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=3522465627&u=https%3A%2
F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%25
2Fwww.bioworld.com%252Farticles%252F697341-let-there-be-walk-onward-medi
cal-sees-first-use-of-movement-restoring-lead%26data%3D05%257C02%257CCat
herine.Daniel%2540Clarivate.com%257Cedc5fea15e914277fdcd08dca1c9b39b%257
C127fa96e00b4429e95f972c2828437a4%257C0%257C0%257C638563134905146044%257
CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1
haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DUNZZrjCw2jYdhPFFfBa
uUjXEs9%252FuWR32WnTRmsvv4k4%253D%26reserved%3D0&a=Let+there+be+walk%3A+
Onward+Medical+sees+first+use+of+movement-restoring+lead] The
researchers who enabled patients with spinal cord injuries to walk
independently after implanting programmable electrodes below their
lesions have now taken things one step further, restoring direct
communication from the brain to the spinal cord, enabling the brain
rather than an external computer to direct leg movements.
-- Award for Publication Excellence - Writing the Entire Issue Category:
Jennifer Boggs, Karen Carey, Anette Breindl, Mari Serebrov, Marian Chu,
Vinod Kamalakannan, Lee Landenberger, Harini Mathavan, Randy Osborne,
Caroline Richards, Tamra Sami, Ann Marie Griffith, Amanda Lanier
BioWorld - June 6, 2023
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=1668628865&u=https%3A%2
F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%25
2Fwww.bioworld.com%252Fnewsletters%252F1%252Fissues%252F35554%26data%3D0
5%257C02%257CCatherine.Daniel%2540Clarivate.com%257Cedc5fea15e914277fdcd
08dca1c9b39b%257C127fa96e00b4429e95f972c2828437a4%257C0%257C0%257C638563
134905152578%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2l
uMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DuXm
a2Y8ZCGgduaq1P1sTDh0PDV8I9S7vo%252BH73DU7oJE%253D%26reserved%3D0&a=BioWo
rld+-+June+6%2C+2023] This issue exemplifies the typical content
delivered every business day, featuring nine stories and a podcast
covering global industry news. Highlights include a series A financing
for a gene therapy company, phase III data from the American Society of
Clinical Oncology conference, an M&A that took a public company private,
and a comprehensive infographic on R&D spending.
-- Award for Publication Excellence in Design & Illustration - Infographics
Category: Ann Marie Griffith and Amanda Lanier, BioWorld Top trends in
2023's post-pandemic economy
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2580563292&u=https%3A%2
F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%25
2Fwww.bioworld.com%252Feconomy2023%26data%3D05%257C02%257CCatherine.Dani
el%2540Clarivate.com%257Cedc5fea15e914277fdcd08dca1c9b39b%257C127fa96e00
b4429e95f972c2828437a4%257C0%257C0%257C638563134905160225%257CUnknown%25
7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVC
I6Mn0%253D%257C0%257C%257C%257C%26sdata%3DhQlo7fb7czafFw6hBPFVo258EkU7Cx
gdJ0aNCAec9Lg%253D%26reserved%3D0&a=Top+trends+in+2023%27s+post-pandemic
+economy] This infographic provides a visual illustration of the impact
that financial investment, licensing deals and M&As have on the
biopharma industry's ability to advance innovation. It gives a
historical perspective of how 2023 fits into the bigger picture and
includes expert commentary and graphics packed with data, assessing the
biopharma industry's overall health.
-- Awards for Publication Excellence in Writing - Series Category: Tamra
Sami and Mari Serebrov, BioWorld, Anette Breindl, BioWorld Science
Radiopharmaceuticals: The next big disrupter?
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=967909301&u=https%3A%2F
%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252
Fwww.bioworld.com%252Fradiopharmaceuticals%26data%3D05%257C02%257CCather
ine.Daniel%2540Clarivate.com%257Cedc5fea15e914277fdcd08dca1c9b39b%257C12
7fa96e00b4429e95f972c2828437a4%257C0%257C0%257C638563134905168266%257CUn
known%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haW
wiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DquKDmZtcY5AMD5OjyVXXUb
IRRwAjPAXipigZs1xJATI%253D%26reserved%3D0&a=Radiopharmaceuticals%3A+The+
next+big+disrupter%3F] Radiopharmaceuticals have been used for a long
time for diagnostics, but radiopharma therapies are entering a new era
in which they are becoming widely accepted as a key tool in the oncology
armamentarium potentially providing patients with a big bump in efficacy
with fewer side effects and less damage to healthy tissue. In this
eight-part series, BioWorld takes a deep dive into this new treatment
modality to explore what the new uses or alternatives are and what the
future of radiopharmaceutical therapy might look like.
-- Awards for Publication Excellence in Writing - News Category: Karen
Carey, BioWorld Wegovy wows investors, sends ripples throughout GLP-1
developer space
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2481480613&u=https%3A%2
F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%25
2Fwww.bioworld.com%252Farticles%252F699807-wegovy-wows-investors-sends-r
ipples-throughout-glp-1-developer-space%26data%3D05%257C02%257CCatherine
.Daniel%2540Clarivate.com%257Cedc5fea15e914277fdcd08dca1c9b39b%257C127fa
96e00b4429e95f972c2828437a4%257C0%257C0%257C638563134905174431%257CUnkno
wn%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiL
CJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DidTz8ddoWfC7kvtwpfUveLKQd
9f42%252F9kjfBvVAoPcjo%253D%26reserved%3D0&a=Wegovy+wows+investors%2C+se
nds+ripples+throughout+GLP-1+developer+space] Investors have known for
some time that the GLP-1 receptor agonist class offers tremendous
promise for treating the underserved obesity population worldwide, but
news from Novo Nordisk A/S on cardiovascular outcomes data sent a shiver
throughout the space.
-- Awards for Publication Excellence in Writing - Mental Health Category:
Anette Breindl, BioWorld Science ECNP 2023: Boosting fear unlearning is
one avenue toward treating PTSD
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=1768432370&u=https%3A%2
F%2Fwww.bioworld.com%2Farticles%2F701648-ecnp-2023-boosting-fear-unlearn
ing-is-one-avenue-toward-treating-ptsd%3Fv%3Dpreview&a=ECNP+2023%3A+Boos
ting+fear+unlearning+is+one+avenue+toward+treating+PTSD] For most
psychiatric illnesses, the precipitating event is mysterious. Many
conditions are thought to result from a mix of genetic risk and
environmental factors, but the specific trigger remains unknown. In
post-traumatic stress disorder (PTSD), the environmental trigger is
usually clear. In many cases, it is all the affected individuals can
think about. "Intrusive reliving" of the triggering situation is one of
the core features of PTSD.
-- Awards for Publication Excellence in Writing - Financial and Investment
Category: Amanda Lanier, BioWorld Larger value, fewer transactions:
biopharma deals up modestly while M&As soar 80% in 2023
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2517695335&u=https%3A%2
F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%25
2Fwww.bioworld.com%252Farticles%252F704682-larger-value-fewer-transactio
ns-biopharma-deals-up-modestly-while-m-and-as-soar-80-in-2023%26data%3D0
5%257C02%257CCatherine.Daniel%2540Clarivate.com%257Cedc5fea15e914277fdcd
08dca1c9b39b%257C127fa96e00b4429e95f972c2828437a4%257C0%257C0%257C638563
134905186318%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2l
uMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DoAB
DEEOqkgKqLjobRmfVKth3eXAokHP7eV1ObMHoi3I%253D%26reserved%3D0&a=Larger+va
lue%2C+fewer+transactions%3A+biopharma+deals+up+modestly+while+M%26As+so
ar+80%25+in+2023] The landscape of biopharma deals and M&As has seen a
transformative shift, with a year-over-year drop in transaction numbers
while value has increased. Overall, biopharma deals saw an uptick in
value of nearly 6%, and biopharma M&As concurrently soared 80% higher in
value than the previous year.
-- Awards for Publication Excellence in Writing - Economics/The Economy
Category: Marian (YoonJee) Chu and Tamra Sami, BioWorld Asia biotech
ecosystems roaring back in 2023
[https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=81230366&u=https%3A%2F%
2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252F
www.bioworld.com%252Farticles%252F703888-asia-biotech-ecosystems-roaring
-back-in-2023%26data%3D05%257C02%257CCatherine.Daniel%2540Clarivate.com%
257Cedc5fea15e914277fdcd08dca1c9b39b%257C127fa96e00b4429e95f972c2828437a
4%257C0%257C0%257C638563134905192533%257CUnknown%257CTWFpbGZsb3d8eyJWIjo
iMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C
%257C%257C%26sdata%3DwLYtXmxF7wsfypZOYuuJfxivkq%252BhUwDyBaDta7svSH8%253
D%26reserved%3D0&a=Asia+biotech+ecosystems+roaring+back+in+2023] If the
COVID-19 pandemic shocked countries to build self-reliance in biomedical
ecosystems, the re-opening of borders in 2023 kickstarted international
collaborations to grow major biohubs in Asia. Countries in the Asia
Pacific region - including Singapore, China, Japan, Korea and Australia
- increasingly drew overseas investors and collaborators, helping each
country grow national biotech capabilities and expertise.
Join the conversation and mention BioWorld on X [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=1899581452&u=https%3A%2F%2Ftwitter.com%2Fbioworld&a=X] at BioWorld [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2826088335&u=https%3A%2F%2Ftwitter.com%2Fbioworld&a=BioWorld], BioWorldMedTech [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2523377394&u=https%3A%2F%2Ftwitter.com%2Fbioworldmedtech&a=BioWorldMedTech] and BioWorldScience [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=1570155691&u=https%3A%2F%2Ftwitter.com%2Fbioworldscience&a=BioWorldScience] or on LinkedIn [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2783136094&u=https%3A%2F%2Fwww.linkedin.com%2Fgroups%2F3356116%2F&a=LinkedIn] at BioWorld [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=311570883&u=https%3A%2F%2Fwww.linkedin.com%2Fgroups%2F3356116%2F&a=BioWorld], BioWorld MedTech [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2382780118&u=https%3A%2F%2Fwww.linkedin.com%2Fgroups%2F6694205%2F&a=BioWorld+MedTech] and BioWorld News. [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=4052628567&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F95714734%2Fadmin%2Ffeed%2Fposts%2F&a=BioWorld+News.] Connect with Clarivate for Life Sciences & Healthcare on X [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=3697416086&u=https%3A%2F%2Ftwitter.com%2FClarivateHealth&a=X] and LinkedIn [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=3130685530&u=https%3A%2F%2Fwww.linkedin.com%2Fshowcase%2Fclarivatehealth&a=LinkedIn].
About BioWorld
With writers and editors stationed around the globe, BioWorld published by Clarivate, reports the breaking news - and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld has a long tradition of excellence in journalism. Collectively, the news services have been honored with 61 awards dating back to 1998.
About Clarivate
Clarivate(TM) is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=1360460664&u=https%3A%2F%2Fclarivate.com%2F&a=www.clarivate.com].
Media Contact:
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
newsroom@clarivate.com [mailto:newsroom@clarivate.com]
Logo - https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg [https://c212.net/c/link/?t=0&l=en&o=4213900-1&h=2713772769&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1159266%2FClarivate_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1159266%2FClarivate_Logo.jpg]
View original content:https://www.prnewswire.co.uk/news-releases/bioworld-by-clarivate-celebrates-nine-wins-at-2024-apex-awards-302200201.html [https://www.prnewswire.co.uk/news-releases/bioworld-by-clarivate-celebrates-nine-wins-at-2024-apex-awards-302200201.html]
Photo: https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg Clarivate Plc
